Autres langues Capital Point Ltd.

Actions

Temps Différé TEL AVIV STOCK EXCHANGE 10:20:17 24/09/2026			Varia. 5j.	Varia. 1 janv.
40,10 ^ILa	+0,75%		-4,98%	-20,91%

30/08	Capital Point Ltd. publie ses résultats financiers pour le semestre clos le 30 juin 2026	CI
02/04	Capital Point Ltd. publie ses résultats annuels pour l'exercice clos le 31 décembre 2025	CI

30/08	Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
02/04	Capital Point Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
28/08/25	Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
27/03/25	Capital Point Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
29/08/24	Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
30/03/24	Capital Point Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
24/08/23	Capital Point Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
20/05/20	Therapix Biosciences : Closes A Joint Venture Transaction For its Sleep Indication
15/12/16	Capital Point Ltd. and Meytag High Tech Ventures sold 17.84% stake in Lithotech Medical, Ltd. for ILS 15.9 million.
05/10/16	Capital Point Ltd. sold 0.79% stake in NeuroDerm Ltd. for $3 million.
25/08/16	BioCep Ltd. announced that it expects to receive $0.4 million in funding from Capital Point Ltd. and other investors
26/07/16	RDD Pharma Ltd. announced that it expects to receive $2.9 million in funding from Capital Point Ltd., OrbiMed Advisors, L.L.C., and another investor
29/06/16	Capital Point Ltd. sold 1% stake in NeuroDerm Ltd. for $3.4 million.